Tekcan, DemetAydoğ, ÖzlemGene, GürkanKendirci, NergisNalçacıoğlu, HülyaÖzkaya, Ozan2020-08-302020-08-302018Tekcan, D., Aydog, O., Gene, G., Kendirci, N., Nalcacioglu, H., & Ozkaya, O. (2018). The results of rıtuxımab therapy ın the patıents wıth steroıd dependent nephrotıc syndrome.0931-041X1432-198Xhttps://hdl.handle.net/20.500.12713/742: The patients with steroid dependent nephritic syndrome (SDNS) require prolonged steroid therapy. To reduce the side effects of prolonged steroid therapy, alternative treatments which have steroidsparing effect are required. Alternative treatments include alkylating agents such as cyclophosphamide or chlorambucil, mycophenolate mofetil (MMF), cyclosporine, and more recently rituximab (RTX).eninfo:eu-repo/semantics/closedAccessConference Object331019241925WOS:000443998400372Q1